• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1毒株的不同感染性与病毒进入所需的包膜三聚体数量有关。

Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry.

作者信息

Brandenberg Oliver F, Magnus Carsten, Rusert Peter, Regoes Roland R, Trkola Alexandra

机构信息

Institute of Medical Virology, University of Zürich, Zürich, Switzerland.

Institute of Integrative Biology, ETH Zürich, Zürich, Switzerland.

出版信息

PLoS Pathog. 2015 Jan 8;11(1):e1004595. doi: 10.1371/journal.ppat.1004595. eCollection 2015 Jan.

DOI:10.1371/journal.ppat.1004595
PMID:25569556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4287578/
Abstract

HIV-1 enters target cells by virtue of envelope glycoprotein trimers that are incorporated at low density in the viral membrane. How many trimers are required to interact with target cell receptors to mediate virus entry, the HIV entry stoichiometry, still awaits clarification. Here, we provide estimates of the HIV entry stoichiometry utilizing a combined approach of experimental analyses and mathematical modeling. We demonstrate that divergent HIV strains differ in their stoichiometry of entry and require between 1 to 7 trimers, with most strains depending on 2 to 3 trimers to complete infection. Envelope modifications that perturb trimer structure lead to an increase in the entry stoichiometry, as did naturally occurring antibody or entry inhibitor escape mutations. Highlighting the physiological relevance of our findings, a high entry stoichiometry correlated with low virus infectivity and slow virus entry kinetics. The entry stoichiometry therefore directly influences HIV transmission, as trimer number requirements will dictate the infectivity of virus populations and efficacy of neutralizing antibodies. Thereby our results render consideration of stoichiometric concepts relevant for developing antibody-based vaccines and therapeutics against HIV.

摘要

HIV-1借助包膜糖蛋白三聚体进入靶细胞,这些三聚体以低密度整合在病毒膜中。介导病毒进入需要多少三聚体与靶细胞受体相互作用,即HIV进入化学计量比,仍有待阐明。在此,我们利用实验分析和数学建模相结合的方法对HIV进入化学计量比进行了估计。我们证明,不同的HIV毒株进入的化学计量比不同,需要1至7个三聚体,大多数毒株需要2至3个三聚体才能完成感染。扰乱三聚体结构的包膜修饰会导致进入化学计量比增加,天然存在的抗体或进入抑制剂逃逸突变也会如此。我们的发现突出了生理相关性,高进入化学计量比与低病毒感染性和缓慢的病毒进入动力学相关。因此,进入化学计量比直接影响HIV传播,因为三聚体数量需求将决定病毒群体的感染性和中和抗体的效力。由此我们的结果使得在开发针对HIV的基于抗体的疫苗和治疗方法时考虑化学计量学概念变得相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/37dcdd00a3a0/ppat.1004595.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/117c75aa47bb/ppat.1004595.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/bc2ba493701a/ppat.1004595.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/71f150465930/ppat.1004595.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/0f70416500a2/ppat.1004595.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/cdbfcecbbb96/ppat.1004595.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/37dcdd00a3a0/ppat.1004595.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/117c75aa47bb/ppat.1004595.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/bc2ba493701a/ppat.1004595.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/71f150465930/ppat.1004595.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/0f70416500a2/ppat.1004595.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/cdbfcecbbb96/ppat.1004595.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04b6/4287578/37dcdd00a3a0/ppat.1004595.g006.jpg

相似文献

1
Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entry.HIV-1毒株的不同感染性与病毒进入所需的包膜三聚体数量有关。
PLoS Pathog. 2015 Jan 8;11(1):e1004595. doi: 10.1371/journal.ppat.1004595. eCollection 2015 Jan.
2
The HIV-1 Entry Process: A Stoichiometric View.HIV-1 进入过程:化学计量观点。
Trends Microbiol. 2015 Dec;23(12):763-774. doi: 10.1016/j.tim.2015.09.003. Epub 2015 Nov 2.
3
Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody.模拟每个病毒体中有多少包膜糖蛋白三聚体参与人类免疫缺陷病毒的感染性及其抗体中和作用。
Virology. 2007 Dec 20;369(2):245-62. doi: 10.1016/j.virol.2007.06.044. Epub 2007 Sep 7.
4
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.小鼠对裂解的可溶性HIV-1包膜三聚体的抗体反应在特异性上受到高度限制。
J Virol. 2015 Oct;89(20):10383-98. doi: 10.1128/JVI.01653-15. Epub 2015 Aug 5.
5
Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.1型人类免疫缺陷病毒进入过程中包膜糖蛋白三聚体的化学计量学
J Virol. 2005 Oct;79(19):12132-47. doi: 10.1128/JVI.79.19.12132-12147.2005.
6
Stoichiometric parameters of HIV-1 entry.HIV-1 进入的化学计量参数。
Virology. 2015 Jan 1;474:1-9. doi: 10.1016/j.virol.2014.10.007. Epub 2014 Nov 7.
7
Maturation-dependent HIV-1 surface protein redistribution revealed by fluorescence nanoscopy.荧光纳米成像揭示成熟依赖的 HIV-1 表面蛋白重分布。
Science. 2012 Oct 26;338(6106):524-8. doi: 10.1126/science.1226359.
8
Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.膜锚定HIV-1包膜糖蛋白三聚体与可溶性gp140糖基化谱的比较分析
J Virol. 2015 Aug;89(16):8245-57. doi: 10.1128/JVI.00628-15. Epub 2015 May 27.
9
Lipidomimetic Compounds Act as HIV-1 Entry Inhibitors by Altering Viral Membrane Structure.类脂拟物通过改变病毒膜结构来充当 HIV-1 进入抑制剂。
Front Immunol. 2018 Sep 4;9:1983. doi: 10.3389/fimmu.2018.01983. eCollection 2018.
10
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.预融合HIV-1包膜三聚体与四级结构特异性抗体复合物的免疫原性
J Virol. 2015 Dec 30;90(6):2740-55. doi: 10.1128/JVI.02380-15.

引用本文的文献

1
Single-molecule localisation microscopy approaches reveal envelope glycoprotein clusters in single-enveloped viruses: a potential functional role?单分子定位显微镜技术揭示了单包膜病毒中的包膜糖蛋白簇:一种潜在的功能作用?
Biochem Soc Trans. 2025 Jun 30;53(3):643-652. doi: 10.1042/BST20240769.
2
Capture of fusion-intermediate conformations of SARS-CoV-2 spike requires receptor binding and cleavage at either the S1/S2 or S2' site.捕获严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的融合中间构象需要受体结合以及在S1/S2或S2'位点的切割。
PLoS Pathog. 2025 Apr 8;21(4):e1012808. doi: 10.1371/journal.ppat.1012808. eCollection 2025 Apr.
3

本文引用的文献

1
Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions.天然病毒粒子表面单个HIV-1包膜三聚体的构象动力学
Science. 2014 Nov 7;346(6210):759-63. doi: 10.1126/science.1254426. Epub 2014 Oct 8.
2
Structure and immune recognition of trimeric pre-fusion HIV-1 Env.三聚体融合前HIV-1包膜糖蛋白的结构与免疫识别
Nature. 2014 Oct 23;514(7523):455-61. doi: 10.1038/nature13808. Epub 2014 Oct 8.
3
Partial rescue of V1V2 mutant infectivity by HIV-1 cell-cell transmission supports the domain's exceptional capacity for sequence variation.
Designing an optimized theta-defensin peptide for HIV therapy using in-silico approaches.
利用计算机模拟方法设计用于艾滋病治疗的优化θ-防御素肽。
J Integr Bioinform. 2025 Mar 19;22(1). doi: 10.1515/jib-2023-0053. eCollection 2025 Mar 1.
4
Inter-protomer opening cooperativity of envelope trimers positively correlates with HIV-1 entry stoichiometry.包膜三聚体的原体间开放协同性与HIV-1进入化学计量呈正相关。
mBio. 2025 Apr 9;16(4):e0275424. doi: 10.1128/mbio.02754-24. Epub 2025 Feb 25.
5
Assessing bnAb potency in the context of HIV-1 envelope conformational plasticity.在HIV-1包膜构象可塑性的背景下评估广谱中和抗体(bnAb)的效力。
PLoS Pathog. 2025 Jan 21;21(1):e1012825. doi: 10.1371/journal.ppat.1012825. eCollection 2025 Jan.
6
Applying Flow Virometry to Study the HIV Envelope Glycoprotein and Differences Across HIV Model Systems.应用流场病毒仪研究 HIV 包膜糖蛋白和不同的 HIV 模型系统。
Viruses. 2024 Jun 9;16(6):935. doi: 10.3390/v16060935.
7
Stoichiometry for entry and binding properties of the Env protein of R5 T cell-tropic HIV-1 and its evolutionary variant of macrophage-tropic HIV-1.包膜蛋白进入和结合性质的化学计量学研究:R5 嗜 T 细胞型 HIV-1 及其进化变体巨噬细胞嗜性 HIV-1。
mBio. 2024 Apr 10;15(4):e0032124. doi: 10.1128/mbio.00321-24. Epub 2024 Mar 1.
8
Second site reversion of HIV-1 envelope protein baseplate mutations maps to the matrix protein.HIV-1包膜蛋白基板突变的二次位点回复映射至基质蛋白。
J Virol. 2024 Feb 20;98(2):e0174223. doi: 10.1128/jvi.01742-23. Epub 2024 Jan 9.
9
IFITM1 and IFITM3 Proteins Inhibit the Infectivity of Progeny HIV-1 without Disrupting Envelope Glycoprotein Clusters.IFITM1 和 IFITM3 蛋白在不破坏包膜糖蛋白簇的情况下抑制 HIV-1 子代的感染性。
Viruses. 2023 Dec 7;15(12):2390. doi: 10.3390/v15122390.
10
Broadly neutralizing antibody epitopes on HIV-1 particles are exposed after virus interaction with host cells.HIV-1 粒子上的广谱中和抗体表位在病毒与宿主细胞相互作用后暴露。
J Virol. 2023 Sep 28;97(9):e0071023. doi: 10.1128/jvi.00710-23. Epub 2023 Sep 8.
HIV-1细胞间传播对V1V2突变体感染性的部分挽救支持了该结构域非凡的序列变异能力。
Retrovirology. 2014 Sep 25;11:75. doi: 10.1186/s12977-014-0075-y.
4
How could SNARE proteins open a fusion pore?SNARE蛋白如何打开融合孔?
Physiology (Bethesda). 2014 Jul;29(4):278-85. doi: 10.1152/physiol.00026.2013.
5
Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes.病毒逃避 HIV-1 中和抗体通过连续识别多个表位和免疫型,从而增加了血浆中和广度。
PLoS Pathog. 2013 Oct;9(10):e1003738. doi: 10.1371/journal.ppat.1003738. Epub 2013 Oct 31.
6
HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development.HIV-1可变环2及其在HIV-1感染和疫苗研发中的重要性。
Curr HIV Res. 2013 Jul;11(5):427-38. doi: 10.2174/1570162x113116660064.
7
Mathematical models: a key to understanding HIV envelope interactions?数学模型:理解 HIV 包膜相互作用的关键?
J Immunol Methods. 2013 Dec 15;398-399:1-18. doi: 10.1016/j.jim.2013.09.002. Epub 2013 Sep 13.
8
Antibodies in HIV-1 vaccine development and therapy.HIV-1 疫苗开发和治疗中的抗体。
Science. 2013 Sep 13;341(6151):1199-204. doi: 10.1126/science.1241144.
9
HIV-1 neutralizing antibodies: understanding nature's pathways.HIV-1 中和抗体:理解自然途径。
Immunol Rev. 2013 Jul;254(1):225-44. doi: 10.1111/imr.12075.
10
Influenza-virus membrane fusion by cooperative fold-back of stochastically induced hemagglutinin intermediates.流感病毒通过随机诱导的血凝素中间体的协同折返实现膜融合。
Elife. 2013 Feb 19;2:e00333. doi: 10.7554/eLife.00333.